Everything here is written for people reading research, not running protocols. This page says what that means in practice, and keeps the receipts.

For in-vitro research use only · not for human consumption of any kind.
This publication is owned by the person who runs the supplier catalog it links to. That is stated on every audit rather than buried here, because a disclosure nobody reads is not a disclosure.
Nothing is sold on this domain. There is no cart, no price on any reference page, and the supplier link sits at the bottom of a compound entry rather than the top. Where a price is involved the surface switches to the supplier's own brand so the boundary is visible without being explained.
The short clips on compound pages are filmed by the same person who runs the supplier, on that supplier's stock, and the label is usually in frame. That is deliberate: a reference page about a compound is more useful when you can see the vial the market actually ships. It is not a product placement we were paid for, and it is the same conflict disclosed on every audit — the person holding the vial is the person auditing it.
When a study does not support what our own listing claims, the listing is named in the piece and corrected. The log below counts those, and it is the only proof that matters.
Nothing written in this publication's voice tells anyone what to take. An audit reports what a study administered and names who administered it; the bench tools do arithmetic on numbers you enter. That line is enforced automatically before anything publishes, and on forum posts before they appear, rather than left to a writer's judgement.
Where published sources report dosing, we reproduce what they report with the source attached to the row. Those figures are theirs, not ours: nothing is averaged into a house number, sources that disagree are shown disagreeing, and no figure appears without the name of whoever published it. A dosing table with no source is the thing this publication objects to everywhere else, so the database will not store one.
When we find our own supplier’s listing overstating what a study supports, we correct it in public and count it. That number going up is the point: it is the clearest signal that the editorial is independent of the catalog.
Twenty-nine imported compound descriptions ended with listing boilerplate, including "Certificate of Analysis attached to this listing", on pages that are reference entries and carry no listing at all. The block was stripped from every affected entry.
Both pieces asserted that the certificates behind our listings carry no identity testing. Lot TET-4213-A carries identity, purity, net content, lot identifier, test date, named lab, method and a chromatogram. The passage was wrong about our own paperwork and was rewritten in both articles.
The listing copy described the compound as a 17-amino-acid fragment while the amino acid sequence recorded against it reads seven residues. Caught in review before the audit citing it was published, and the listing was corrected rather than the audit softened.
Seven active supplier listings displayed "COA attached" while the certificate field was empty. The claim was removed from every affected listing. This is the failure our own COA audit describes, found on our own catalog.